The major platelet integrin, ␣IIb␤3, is required for platelet interactions with proteins in plasma and the extracellular matrices (ECMs) that are essential for platelet adhesion and aggregation during hemostasis and arterial thrombosis. Ligand binding to ␣IIb␤3 is controlled by insideout signals that modulate receptor conformation and clustering. In turn, ligand binding triggers outside-in signals through ␣IIb␤3 that, when disrupted, can cause a bleeding diathesis. In the past 5 years there has been an explosion of knowledge about the structure and function of ␣IIb␤3 and the related integrin, ␣V␤3. These developments are discussed here, and current models of bidirectional ␣IIb␤3 signaling are presented as frameworks for future investigations. An understanding that ␣IIb␤3 functions as a dynamic molecular scaffold for extracellular and intracellular proteins has translated into diagnostic and therapeutic insights relevant to hematology and cardiovascular medicine, and further advances can be anticipated. ( 
Introduction
The platelet is a tightly regulated adhesion machine. Restrained in its functions while in the bloodstream, its adhesive, hemostatic, and proinflammatory capabilities are unleashed at sites of vessel injury to generate the primary hemostatic plug, catalyze fibrin formation, and supply soluble and membrane-bound factors that promote wound healing. 1 While platelets can adhere to damaged endothelial cells, 2 their principle adhesive surface is the extracellular matrix (ECM), which becomes exposed in injured vessels and offers a panoply of ligands for platelet adhesion receptors. 3 Within this context, integrin adhesion receptors, and ␣IIb␤3 in particular, play critical roles in platelet function.
Integrins are heterodimeric (␣␤) type I transmembrane receptors, each subunit typically containing a relatively large extracellular domain, a single-pass transmembrane domain, and a short cytoplasmic tail composed of 20 to 60 amino acids. 4 Platelets express several integrins (␣IIb␤3, also called glycoprotein IIb-IIIa [GPIIb-IIIa]; ␣V␤3; ␣2␤1; ␣5␤1; ␣6␤1). Integrins are, in effect, "2-faced" receptors, one face oriented to the extracellular space and interactive with cognate ECM ligands and the other oriented to the cell interior and interactive with cytoplasmic proteins. Ligand binding to either face can trigger information transfer, or signaling, across the plasma membrane to "activate" cellular functions at the other face. Figure 1 illustrates this bidirectional signaling using ␣IIb␤3 as an example.
Basic research conducted in the past 3 decades on many facets of ␣IIb␤3 structure and function has led to remarkable breakthroughs culminating in the development of a chimeric anti-␣IIb␤3 monoclonal antibody and small-molecule receptor antagonists now used parenterally to limit the formation of occlusive platelet thrombi in acute cardiovascular indications. 5, 6 On the other hand, clinical trials of oral ␣IIb␤3 antagonists have been disappointing and suggest that long-term extracellular blockade of ligand binding to ␣IIb␤3 might even be dangerous. Conceivably, then, further basic studies of this proven therapeutic target, and of ␣IIb␤3 signaling in particular, might lead to newer and better ways to diagnose, prevent, or treat arterial thrombosis or other consequences of ␣IIb␤3 dysfunction. The purpose of this review is to highlight recent experimental and conceptual advances in the integrin field that are particularly relevant to ␣IIb␤3 and platelets. It will draw from structural analyses of integrins and studies of human and mouse platelets, with the caution that platelets from these 2 species are similar but not identical. [7] [8] [9] Several excellent general reviews of integrin signaling are also available. 4, [10] [11] [12] [13] [14] [15] [16] Structural basis of ␤3 integrin signaling
Structure of the ␣IIb␤3 extracellular domain
Our first glimpse into ␣IIb␤3 structure was provided nearly 20 years ago when approximately 230-kDa ␣IIb␤3 complexes were purified from detergent-solubilized platelet membranes and visualized by electron microscopy. 17 Rotary-shadowed, negatively stained images revealed an approximately 23-nm (230-Å) complex consisting of an approximately 8-nm (80 Å) globular head and 2 approximately 16-nm (160 Å) flexible stalks. In the absence of detergent, ␣IIb␤3 aggregated into rosettes that appeared to be contacting each other at the tips of their stalks (Figure 2A-B) . Following the cloning of ␣IIb and ␤3 and using epitope-mapped antibodies, Weisel and colleagues 18 correctly deduced that the stalks contain the C-terminal, transmembrane domain-containing segment of each subunit, and the globular head contains the N-terminal portions. These investigators also found that fibrinogen, von Willebrand factor (VWF), and fibronectin interact with the globular head ( Figure 2C-D) , thus identifying this domain as containing the ligand contact site. These findings were corroborated by the demonstration of fibrinogen binding to a recombinant ␣IIb␤3 head domain lacking the ␤3 stalk. 19 A number of early models of integrin structure, such as the one shown in the top left panel of Figure 3 , were developed based on electron microscopic images, peptide and epitope mapping, photoaffinity and chemical cross-linking, and biochemical analyses of cysteine disulfide-bonding patterns. Portrayed were such structural features as (1) an ␣IIb subunit composed of an approximately 120-kDa heavy-chain disulfide bonded to an approximately 23-kDa light chain; (2) 4 ␣IIb calcium-binding domains; (3) a small N-terminal cysteine-rich domain in ␤3 attached by a disulfide bond to "cysteine-rich repeats" within the body of the molecule; and (4) a large, protease-sensitive "disulfide-bonded loop" within ␤3 bounded by residues 121 and 348 and containing the major ligand-binding sites.
Recent determination of the crystal structure of the extracellular segment of ␣V␤3 has provided a major advance. 20 Remarkably, many of the structural and functional domains predicted in earlier models are recognizable in the 12 domains identified in the crystal, albeit with much higher resolution, and with some notable surprises. As shown in Figure 3 , the 4 Ca 2ϩ -binding domains in ␣V are part of a ␤-propeller, the structure of which had been predicted. 21 A large immunoglobulin-like "thigh" domain comprises the remainder of the ␣V subunit's contribution to the integrin headpiece. In ␤3, the N-terminal cysteine-rich segment has become the plexin/ Figure 1 . Integrin activation is bidirectional and reciprocal. The ␣IIb␤3 equilibrates between resting and activated states, the resting state predominating in unstimulated platelets and the activated state in stimulated platelets. Conversion from resting to activated does not imply a single, abrupt change but rather a series of coordinated and linked conformational transitions. (A) Inside-out signaling. Agonistdependent intracellular signals stimulate the interaction of key regulatory ligands (such as talin) with integrin cytoplasmic tails (in this case the ␤3 tail). This leads to conformational changes in the extracellular domain that result in increased affinity for adhesive ligands such as fibrinogen, von Willebrand factor (VWF), and fibronectin. Affinity modulation can be monitored in living cells with engineered monovalent Fab fragments derived from ligand-mimetic monoclonal antibodies. 35, 50, 137 Plasma fibrinogen and VWF support platelet aggregation at low and high shear rates, respectively, by bridging ␣IIb␤3 receptors on adjacent platelets. 3 Studies in mice deficient in fibrinogen and VWF indicate that plasma fibronectin can also promote thrombus initiation, growth, and stability at high shear rates. 138 (B) Outside-in signaling. Extracellular ligand binding, initially reversible, becomes progressively irreversible and promotes integrin clustering and further conformational changes that are transmitted to the cytoplasmic tails. This results in the recruitment and/or activation of enzymes, adaptors, and effectors to form integrin-based signaling complexes. semaphorin/integrin (PSI) domain, while the former ligand-binding large disulfide-bonded loop emerges from a discontinuous, immunoglobulin-like hybrid domain in the form of an adhesive "I-like" or A domain. Finally, the previously observed ␣V stalk is now composed of 2 rigid "calf" modules, and the former cysteine-rich repeats of the ␤3 stalk have morphed into 4 endothelial growth factor (EGF)-like domains, which, together with a novel flowerlike structure termed the ␤-terminal domain (␤TD), completes the stalk. Comparison of the predicted structures of ␣IIb␤3 with those actually found in the ␣V␤3 crystal can be found in Table 1 .
Several groups have attempted to reconcile the ␣V␤3 crystal structure with electron microscopic images analyzed with refined methods. 15, 22 In one example, electron cryomicroscopy was used to derive a 2-nm (20-Å) resolution Fourier shell transformation density map of hydrated ␣IIb␤3 complexes frozen in a low-affinity, unliganded state. Taking liberties to introduce a few kinks into the flexible hinge regions within the 2 subunits, the authors were able to visually fit the 12 domains of ␣IIb␤3 into the extracellular region of their 3-dimensional contour map. They suggest that their model may represent the structure of ␣IIb␤3 as it exists in the surface membrane of resting platelets. 22 
Structure of ␣IIb␤3 transmembrane and cytoplasmic domains
Since the short cytoplasmic tails of ␣IIb and ␤3 play key roles in signaling, much attention has focused on whether they have an ordered 3-dimensional structure and how they might interact with each other and with intracellular proteins. Vinogradova et al 23 were the first to determine a nuclear magnetic resonance (NMR) structure for a membrane-anchored form of an isolated ␣IIb tail and found that it formed an N-terminal ␣-helix followed by a turn predicted to straighten out upon integrin activation. Ulmer et al 24 employed NMR spectroscopy to analyze the ␣IIb and ␤3 cytoplasmic tails in aqueous solution and found them to be largely unstructured, with a tendency for the N-terminus of ␤3 to form a helix and the downstream NPLY 747 motif to form a reverse turn that could support talin binding. Interestingly, neither these authors nor Li and colleagues 25 could find any evidence for interaction between the ␣IIb and ␤3 tails themselves, despite the fact that the latter group expressed the tails in a relatively native state-that is, attached to their respective transmembrane domains buried in phospholipid. Rather, the transmembrane domains, which were present in a largely ␣-helical conformation, actually promoted the formation of homodimers and homotrimers. Based on the observation that certain mutations within the ␤3 transmembrane domain enhance the tendency to form ␣IIb-␣IIb and ␤3-␤3-␤3 homomeric associations, while at the same time conferring constitutive fibrinogen-binding activity, these workers proposed that homomeric transmembrane helix associations might drive subunit reshuffling to increase receptor clustering and avidity for ligand. 26 On the other hand, cysteine scanning mutagenesis of the ␣IIb and ␤3 transmembrane domains in the context of the full-length integrin expressed in model cell systems suggests that interactions through a specific heterodimer interface help to maintain the default low-affinity state of the integrin. Furthermore, separation of the transmembrane helices is linked to an increase in ␣IIb␤3 affinity for ligands. 27 Since a portion of the integrin residues involved in the transmission of bidirectional signals are embedded in the plasma membrane, 28, 29 the structure and function of the ␣IIb␤3 transmembrane domains clearly warrant further investigation.
In contrast to the above studies, several others have found evidence that integrin cytoplasmic tails can and do interact with each other, and in some cases the nature of the interaction appears to change as a consequence of inside-out activation. A tightly packed approximately 3-nm (30-Å) long cylindrical rod was observed in the region of the ␣IIb␤3 transmembrane domain by electron cryomicroscopy, corresponding to a pair of tightly packed, parallel, right-handed ␣-helical coils. 22 The cytoplasmic domains could be seen extending from the transmembrane ␣-helix as a single, cohesive, heart-shaped density of approximately 7 kDa. Two recent NMR structures also show extensive, although somewhat contradictory, interactions between ␣IIb and ␤3 cytoplasmic tails near the membrane-proximal interface of each tail. 30, 31 The latter structure showed intersubunit contacts composed of hydrophobic and hydrostatic interactions mediated by amino acid residues highly conserved among integrins. A recent study has shown that in the presence of membrane-mimetic micelles, the cytoplasmic faces of the ␣IIb and ␤3 cytoplasmic tails and the NPLY region of ␤3 become embedded in the membrane, a conformation that differs Cysteine-rich repeats EGF repeats Protease-resistant stalk composed of 4 repeating EGF domains that may broker integrin conformational changes.
NA indicates not applicable; and SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
importantly from that observed in a strictly aqueous environment. Furthermore, the binding of purified talin to ␤3 caused unclasping of the tails and changes in tail-membrane interactions ( Figure 4A ). 32 These in vitro results are largely consistent with fluorescence resonance energy transfer (FRET) studies of green fluorescence protein (GFP)-tagged ␣L and yellow fluorescent protein (YFP)-tagged ␤2 subunits in living cells. 33 Based on changes in FRET, the cytoplasmic tails were calculated to be close to each other in resting cells but become separated by up to 10 nm (100 Å) following either ligand binding to ␣L␤2 or agonistinduced cellular activation. Overall, these data provide compelling evidence that intersubunit cytoplasmic tail associations, and possibly heterodimeric transmembrane associations, function to maintain the ␣IIb␤3 complex in a resting, nonadhesive conformation, while disruption of these interactions causes separation of the tails and propagated changes in the extracellular domains to increase ␣IIb␤3 affinity.
Conformational changes associated with ␤3 integrin activation
Several observations indicate that the extracellular domains of ␣IIb␤3 and ␣V␤3 must undergo conformational transitions upon cellular activation or ligand binding. First, activation of platelets or endothelial cells induces the binding of arginine-glycine-aspartic acid (RGD)-containing antibody Fab fragments to ␣IIb␤3 and ␣V␤3, respectively. 34, 35 In the case of ␣IIb␤3, Fab binding requires discontinuous regions of the ␣IIb ␤-propeller and the ␤3 A domain. 36 Second, when platelets are activated by agonists, a change in FRET is observed between fluorophore-conjugated antibodies bound to ␣IIb and ␤3. 37 Finally, anti-␣IIb or anti-␤3
antibodies of the ligand-induced binding sites (LIBS) type preferentially recognize the ligand-occupied form of the integrin, and they in turn increase receptor affinity. In terms of primary amino acid sequence, the epitopes for many of these LIBS antibodies are located a relatively long distance from the ligand-binding headpiece, suggesting that the integrin is subject to long-range conformational changes. 38 Differences in ␣V␤3 structure have been visualized in negatively stained electron microscopic images of the integrin in apparent low-and high-affinity states. 39 The low-affinity, unliganded form was present as a compact, V-shaped structure highly reminiscent of the bent conformation found in the crystal structure of ␣V␤3 (Figure 3 ), becoming extended upon ligand binding into the "head ϩ 2 tails" configuration previously visualized by other investigators (eg, Figure 2 ). This transition has been described as analogous to a "switchbladelike" movement such that the extended form may represent the ligand-bound high-affinity receptor. However, a less drastic change may be all that is required for initial transformation of ␤3 integrins from low-to high-affinity state. Coined the "deadbolt" model, 14 inside-out signals are postulated to transmit conformational changes through the transmembrane helices into the immediately proximal ␤TD. The CD loop of the ␤TD, which in resting integrins acts like a deadbolt to pin the F/␣7 loop of the ␤A domain forward to obstruct contact with macromolecular ligands (Figure 4B ), then moves out of the way, allowing the F/␣7 loop to swing away from the ligand contact site, making it available for productive, high-affinity ligand binding.
Experimental evidence that displacement of the F/␣7 loop is involved in ligand binding comes from studies of ␣L␤2, where mutational shortening of the ␤2 ␣-helix by approximately one turn resulted in a constitutively active receptor. 40 One of the most attractive features of this model is that larger-scale structural changes are not required to convert ␤3 integrins into high-affinity receptors. Furthermore, the model does not preclude switchbladelike straightening of the bent integrin or separation of the cytoplasmic tails, both of which are likely to promote outside-in signaling in response to ligand binding. Additional studies are required to rigorously test and refine existing models of integrin activation and, in particular, to fully understand coordinated transitions among the integrin extracellular, transmembrane, and cytoplasmic domains, molecular movements that will likely affect outside-in as well as inside-out signaling.
Integrin clustering
In addition to conformational changes, cell activation promotes the lateral mobility and clustering of integrins within the plane of the plasma membrane. 41 Initially, small oligomers or "microclusters" below the resolution of the light microscope may contribute to "avidity" or "valency" regulation of ligand binding. 15, 42 Microclustering in native membranes or living cells has been difficult to study, but new techniques are beginning to open up this area of investigation. 33, 43 The ␣IIb␤3 clustering may be promoted by several mechanisms, including the binding of multivalent ligands, 43, 44 ligand self-association, 45, 46 lateral interactions of integrins with other membrane proteins, 47 reversible integrin linkages to the actin cytoskeleton, 48 and homomeric interactions of the transmembrane domains. 26 Integrin conformational change and clustering are not mutually exclusive; they are complementary and may even be mechanistically linked. Each may be involved in different aspects of bidirectional signaling. For example, conformational change seems to be the dominant way in which ligand binding to ␣IIb␤3 and ␣V␤3 is regulated, while clustering is The deadbolt model of inside-out integrin activation. In the nonactivated integrin, the elongated CD loop of ␤TD is in close proximity to the ␤A domain, allowing it to effectively "deadbolt" the F/␣7 loop in place, preventing ligands (transparent blue circle) from making contact with ␤A residues necessary for high-affinity binding. Inside-out signaling is hypothesized to induce conformational changes in the cytoplasmic tails that when transmitted through the transmembrane domains would unlock the deadbolt. The resulting loss of constraints imposed by the CD loop would allow the F/␣7 loop to rock back (exaggerated as shown) from the ligand contact site, making the latter available for binding. Certain LIBS antibodies may also move the deadbolt, promoting ligand binding independent of inside-out signals. Adapted from Xiong et al 14 with permission.
important in triggering activation of Src and Syk protein tyrosine kinases during outside-in signaling. [49] [50] [51] Biochemical basis of ␤3 integrin signaling
Regulation of inside-out signaling: excitatory and inhibitory agonist receptors
Binding of adhesive ligands to ␣IIb␤3 can be triggered by soluble agonists, such as adenosine diphosphate (ADP), thrombin, epinephrine, and thromboxane A 2 , which engage cognate G-proteincoupled receptors. 9 In addition, certain platelet adhesion receptors, notably GPIb-IX-V (the primary receptor for VWF), GPVI (collagen), ␣2␤1 (collagen), and even ␣IIb␤3, can trigger activation signals when bound to and clustered by ECM ligands. 3, [52] [53] [54] The relative contribution of soluble and ECM stimuli to inside-out signaling likely varies with flow conditions and other circumstances of vascular injury. For example, GPIb-IX-V function is most relevant under conditions of high shear typical of the arteriolar and capillary circulations and in stenotic arteries. 3 An important but under-studied process is inhibition or reversal of ligand binding to ␣IIb␤3. Activation of ␣IIb␤3 is negatively regulated in a complex manner by cyclic adenosine monophosphate (AMP) and cyclic guanosine monophosphate (GMP), generated by interaction of platelets with prostacyclin (PGI 2 ) and nitric oxide (NO), respectively, 9 and by an endothelial cell ecto-ADPase (CD39). 55 In mouse platelets, the excitatory function of GPVI and GPIb-IX-V is partly dependent on the associated FcR ␥-chain, whose tyrosine-phosphorylated immunoreceptor tyrosine-based activation motifs (ITAMs) help recruit tyrosine kinases to these receptors. 53, 54 Signaling through GPVI and GPIb-IX-V is dampened by platelet endothelial cell adhesion molecule 1 (PECAM-1), an immunoglobulin superfamily receptor whose immunoreceptor tyrosine-based inhibitory motifs (ITIMs) recruit SHP-1 (Src homology 2 [SH2] domain-containing tyrosine phosphatase 1) and SHP-2 tyrosine phosphatases. [56] [57] [58] 
Signaling intermediates that link agonist receptors to ␣IIb␤3
Receptors couple to second messengers such as Ca 2ϩ , cyclic nucleotides, and products of phospholipases and tyrosine kinases. 9,53 A major gap remains in how second messengers effect functional changes in ␣IIb␤3. For example, protein kinase C (PKC), phosphatidylinositol 3-kinase (PI 3-kinase), and Rap1b have been implicated as intermediates in promoting inside-out signaling, but the identities and activities of the relevant effectors of these enzymes remain to be determined. 9, 59 Rap1b serves as a timely case in point.
Rap1 is a member of the Ras family of small guanosine triphosphatases (GTPases) and has been implicated generally in promoting cell adhesion and migration through effects on affinity and/or avidity modulation of integrins. 60 Rap1b, the predominant isoform in platelets, cycles from a guanosine diphosphate (GDP)-bound inactive state to a GTP-bound active state upon addition of agonists to Gi-coupled receptors, 61, 62 binding of collagen to GPVI, 63 and even binding of fibrinogen to ␣IIb␤3. 64 Rap1b associates with the actin cytoskeleton of activated platelets and is a substrate for protein kinase A, although the effect of this phosphorylation is unknown. 64 A link between Rap1b and affinity modulation of ␣IIb␤3 has been established in primary murine megakaryocytes. 35, 65 Overexpression of a constitutively active Rap1b mutant or of CalDAG-GEFI, a Rap exchange factor, potentiates agonistinduced fibrinogen binding to ␣IIb␤3, and this effect is blocked by inhibitors of actin polymerization. Overexpression of Rap1-GTPaseactivating protein (Rap1-GAP), which converts Rap1-GTP to Rap1-GDP, partially blocks agonist-induced fibrinogen binding, suggesting that endogenous Rap1b promotes, but is not sufficient for, inside-out signaling, perhaps through some effect on the actin cytoskeleton. This interpretation is consistent with the recent observation that Rap1b-deficient mouse platelets undergo reduced aggregation responses to agonists. 66 Interestingly, CalDAG-GEFI contains a C1 domain that may bind diacylglycerol and an EF hand domain that binds Ca 2ϩ . 60 Consequently, generation of these second messengers by phospholipase C could provide one means by which Rap1b activity is regulated in platelets. However, other exchange factors for Rap1b have been identified 60 and some may be expressed in platelets. Rap1b effectors involved in ␣IIb␤3 signaling have yet to be identified. In this context, RAPL is a Rap1-GTP-binding protein that reportedly coimmunoprecipitates with and clusters ␣L␤2 when T lymphocytes are activated by chemokines. 67 Its presence and function in platelets have not been determined.
Proximal regulation of ␣IIb␤3 by integrin-binding proteins
In theory, ligand binding to ␣IIb␤3 could be regulated by integrin interactions with intracellular, extracellular, or transmembrane molecules. RGD-containing ligands, even short peptides, can stabilize the high-affinity conformation of purified ␣IIb␤3. 68 In platelets, MnCl 2 or LIBS antibodies convert ␣IIb␤3 into a highaffinity conformation. 69 Some have speculated that certain ␣IIb␤3 antagonists or soluble CD40 ligand may exert similar effects in vivo 6, 70 and that some drug-dependent anti-␣IIb␤3 antibodies may recognize LIBS epitopes exposed by binding of the drug. 71, 72 Reducing agents such as dithioethreitol can activate purified or platelet ␣IIb␤3, as can mutation of single cysteines within the ␤3 EGF repeats. 73 The platelet surface and ␤3 integrins in particular are reported to possess thiol isomerase activity, 74, 75 leading to the proposition that disulfide exchange may help to regulate ␣IIb␤3 activation. 76, 77 Also, a pool of ␣IIb␤3 may form complexes with CD9 (a tetraspanin) 47 or CD47 (a thrombospondin receptor). 78 The relationship between CD47 and ␣IIb␤3 appears particularly complex. Specific peptides from thrombospondin can bind to CD47 and activate platelet G proteins, providing one way for CD47 to regulate ␣IIb␤3. 78 In addition, platelet CD47 can interact with receptors in activated endothelial cells, leading to ␣IIb␤3 activation. 79 Finally, the extracellular portion of CD47 bound to a thrombospondin peptide can directly modulate ␣IIb␤3 activation state in Chinese hamster ovary (CHO) cells. 80 Despite these observations, no platelet aggregation abnormalities have been reported in CD47-deficient mice.
Evidence to date indicates that any role for extracellular or transmembrane molecules in affinity modulation is secondary to ␣IIb␤3 regulation by intracellular proteins, and in particular talin, which engage the integrin cytoplasmic tails. Talin1 is an approximately 270-kDa antiparallel dimer composed of an approximately 50-kDa N-terminal FERM domain, which contains F1-3 subdomains and assumes a phosphotyrosine-binding (PTB) domain-like fold, and an approximately 220-kDa C-terminal rod domain ( Figure 5 ). [81] [82] [83] F2-3 contains a major binding site for integrin ␤ cytoplasmic tails and several other proteins, including type I␥ phosphatidylinositol phosphate kinase (PIPKI␥), an enzyme responsible for generating the lipid second messenger, PIP 2 . 84 The rod domain, separated from the FERM domain by a calpain cleavage site, contains the major binding sites for F-actin.
Interest in talin as an integrin regulator comes from several lines of investigation. First, talin (or F2-3) binds specifically to integrin ␤ tails in vitro, including ␤1, ␤2, and ␤3. 82, [85] [86] [87] [88] Second, overexpression of the FERM or F2-3 domains activates ␣IIb␤3 in CHO cells. 82, 86, 88 Third, as depicted in Figure 4A , NMR, x-ray crystallographic, and FRET analyses are consistent with the idea that talin interacts with the N-terminus and midportion of ␤ tails, thereby splaying the ␤ and ␣ tails and modifying their interactions with the membrane. 31, 33, 89, 90 Fourth, mutations in talin F2-3 or ␤ tails predicted to disrupt their interaction also eliminate integrin activation in CHO cells. 88 Thus, the inability to bind talin may explain the thrombasthenic phenotype of human platelets where the membranedistal half of the ␤3 tail has been deleted. 91 Finally, knockdown of talin in CHO cells and megakaryocytes by RNA interference ablates energy-dependent activation of ␤1 and ␤3 integrins. 88 Important questions remain about the proximal regulation of ␣IIb␤3. How is talin's recruitment to the platelet membrane and to ␣IIb␤3 regulated by agonists? 92 Perhaps talin transforms from a compact "autoinhibited" conformation to an open conformation in response to activation signals, analogous to several other proteins that influence the actin cytoskeleton, such as vinculin, WiskottAldrich syndrome protein (WASP), and PAK (p21-activated kinase). Signaling events hypothesized to regulate talin include PIP 2 binding, 93 serine-threonine phosphorylation, 94 and proteolysis by calpain. 95 In addition, Src-dependent tyrosine phosphorylation of PIPKI␥ may increase its ability to compete with integrin ␤ tails for talin, 96 and tyrosine phosphorylation of ␤ tails may reduce their binding to talin. 94 Does talin regulate integrin avidity as well as affinity? Talin's role in linking integrins to actin filaments, in clustering of integrins into adhesion complexes, and in force generation at the cell-ECM interface certainly place it in a position to do so. 81, 97, 98 Finally, do other integrin cytoplasmic tail-binding proteins regulate ␣IIb␤3 affinity? Both calcium and integrin binding protein (CIB), which binds to ␣IIb, and ␤3 endonexin, which binds to ␤3, activate ␣IIb␤3 in model cell systems. [99] [100] [101] However, ␤3 endonexin does not activate ␣IIb␤3 in the absence of talin, 88 and determining the inside-out functions of this and other tail-binding proteins in platelets requires further study.
Regulation of outside-in signaling
Maximal secretory, procoagulant, and clot retraction responses of platelets generally require ligand binding to ␣IIb␤3 and close platelet-platelet contact. The term "contact-dependent signaling" has been used to describe this phenomenon, in which other ligand-receptor pairs have also been implicated, including ephrin/ Eph receptor kinases, CD40 ligand/CD40, and Gas6/Axl-Sky-Mer receptor kinases. 70, [102] [103] [104] The best understood example of contactdependent signaling is outside-in signaling through ␣IIb␤3. 105 Platelet adhesion to fibrinogen or VWF triggers morphologic changes ranging from filopodial and lamellipodial extension to full spreading. [106] [107] [108] [109] As in nucleated cells, these changes are mediated by effectors of the Rho GTPases, cdc42, Rac1, and Rho A. 107, 110 The morphologic changes are associated with dynamic modifications of the actin cytoskeleton that affect the polymerization state and organization of actin. 109, 111 ␣IIb␤3 participates in this process by nucleating signaling complexes at adhesion sites that regulate actin. 106, 109, 112, 113 Platelets and ␣IIb␤3-expressing CHO cells adherent to fibrinogen have frequently been used as model systems to study this process. In both cases, outside-in signaling occurs in a discrete pattern whereby ligand binding initiates integrin clustering and assembly of a nascent signaling complex proximal to the cytoplasmic tails of ␣IIb␤3, followed by the growth of a larger actin-based signaling complex.
Initiation of outside-in signaling
Among the earliest detectable biochemical responses of platelets to fibrinogen binding is activation of Src and Syk protein tyrosine kinases. 112 Occupancy of ␣IIb␤3 by fibrinogen causes integrin microclustering, 43 ,44 which appears necessary for this tyrosine kinase activation. 49, 51 Although some monovalent ligands promote ␣IIb␤3 homo-oligomerization in detergent solution, 114 there is no unequivocal evidence yet that they do so or trigger outside-in signaling in vivo. Soluble CD40 ligand can bind and induce outside-in signaling through ␣IIb␤3, but it is a trimer, suggesting even in this case that clustering of ␣IIb␤3 is required. 70, 115 Components of a nascent ␣IIb␤3 signaling complex have been identified in platelets and CHO cells based on their ability to coimmunoprecipitate with ␣IIb␤3 or to become rapidly tyrosine phosphorylated by integrin-associated Src or Syk, even in the presence of inhibitors of actin polymerization. 112 Buttressed by studies with purified proteins as well as by detection of specific protein-protein interactions in living cells, 116 the following sequence of events for assembly of the ␣IIb␤3 signaling complex can be envisioned. (1) Src kinases constitutively bound to the ␤3 cytoplasmic tail become activated when fibrinogen engages and clusters ␣IIb␤3 51,112 (Figure 6) . (2) Syk is recruited to the ␤3 tail and activated by Src. 112, 117 (3) Src and/or Syk phosphorylate substrates, including SLP-76, ADAP and c-Cbl (molecular adaptors), and Vav (a Rac GTPase), that are implicated in signaling to the actin cytoskeleton. [118] [119] [120] Propagation of outside-in signaling As the nascent complex assembles, many additional proteins are recruited that are capable of influencing actin dynamics and reorganization. These include Rac, Nck (an adapter), PAK, PI 3-kinase, and vasodilator-stimulated phosphoprotein (VASP), an actin-bundling protein (Figure 7) . Although not all components of the signaling network have been identified, 3 proteins warrant particular discussion here because each is tyrosine phosphorylated by Src and/or Syk during platelet aggregation and spreading and each probably helps to morph nascent complexes into actin-based complexes. These proteins are ␤3 itself, phospholipase C␥, and ␣-actinin. Phosphorylation of the ␤3 cytoplasmic tail at residues 747 and 759 may enhance post-ligand-binding events by generating docking sites for SH2-containing protein (Shc), an adapter in Ras signaling, and myosin, a motor protein involved in clot retraction and stabilization of platelet aggregates. 121, 122 Mice in which these tyrosines have been mutated to phenylalanine exhibit rebleeding from tail wounds and subtle defects in clot retraction and platelet aggregation. 105, 123 Phospholipase C␥ is a substrate of Src and Bruton tyrosine kinase (Btk) kinases, and its activation by tyrosine phosphorylation downstream of ␣IIb␤3 generates some of the diacylglycerol and inositol phosphate (IP3) needed for maximal platelet aggregation and spreading. 113 Diacylglycerol and IP3-dependent Ca 2ϩ fluxes activate conventional and novel isoforms of PKC discussed previously in the context of inside-out signaling. Preliminary studies show that certain PKC isoforms coimmunoprecipitate with ␣IIb␤3 under some conditions, and broad-spectrum PKC inhibitors block platelet spreading on fibrinogen (Churito Buensuceso, Alessandra Soriani, Achim Obergfell, Koji Eto, and S.J.S., unpublished observations, January 2004). Thus, some integrin-associated proteins may regulate both phases of ␣IIb␤3 signaling.
␣-actinin is a homodimeric actin-binding protein that localizes to integrin adhesion sites. The nonmuscle isoform found in platelets contains binding sites for vinculin, zyxin, and the membrane-proximal portions of ␤1, ␤2, and ␤3 integrin cytoplasmic tails. 124 Overexpression of full-length ␣-actinin in fibroblasts leads to stabilization of adhesion sites, while integrin-binding fragments disrupt actin stress fibers, focal adhesions, and mechanotransduction. 125 ␣-actinin becomes tyrosine phosphorylated on a single N-terminal residue in response to platelet aggregation or spreading. 126 Phosphorylation may be mediated by focal adhesion kinase (FAK), whose own activation is dependent on actin polymerization following platelet costimulation through agonist and ␣IIb␤3 receptors. In a model system, tyrosine phosphorylation of ␣-actinin reduced its cosedimentation with F-actin. 126 Therefore, phosphorylation of ␣-actinin during later stages of outside-in signaling might regulate ␣IIb␤3 linkages with actin and the assembly/disassembly of actin-based signaling complexes.
Many facets of outside-in ␣IIb␤3 signaling remain to be explored. What are the identities and functions of the phosphatases that counterbalance the effects of the protein and lipid kinases that operate in integrin signaling? What are the roles in platelets of other proteins, such as skelemin and integrin-linked kinase, reported to interact with the ␣IIb or ␤3 cytoplasmic tails in model systems? 101, 127, 128 Disassembly of ␣IIb␤3-based signaling complexes may be required to achieve full platelet spreading or to limit platelet adhesion and aggregation to the hemostatic plug. How is disassembly regulated? Perhaps it involves ␣IIb␤3-dependent activation of FAK and its effectors. 129, 130 Perhaps it involves specific protein or lipid phosphatases or proteases like calpain, which cleave ␤3, Src, and other proteins upon platelet aggregation. Do the other integrins in platelets engage in bidirectional signaling? Recent investigations of ␣V␤3 and ␣2␤1 suggest that they do. 53, [131] [132] [133] How are they regulated? Perspective ␣IIb␤3 was identified as the platelet fibrinogen receptor over 25 years ago. Ensuing investigations of ␣IIb␤3 and its relative, ␣V␤3, have provided many key insights about integrin structure and function. Some of these have led to improvements in clinical practice, most notably the use of parental ␣IIb␤3 antagonists to prevent arterial thrombosis. Future studies of ␣IIb␤3 signaling promise to yield additional information of clinical relevance. For example, while deficiency of ␣IIb␤3 is rare, specific defects in ␣IIb␤3-related signal transduction may account for many incompletely characterized bleeding disorders associated with defects in Figure 7 . Cartoon depicting portions of the signaling network linking ␣IIb␤3 to actin polymerization and reorganization. The insert provides a key to some of the modules or domains within the proteins that mediate or regulate protein functions and/or interactions. Domain abbreviations: CH, calponin homology; P-Tyr, phosphotyrosine; PTB, phosphotyrosine binding; PH, pleckstrin homology; WH, WASP homology; and VH, verprolin homology. WIP indicates WASP-interacting protein; PLC␥, phospholipase C␥. The figure is offered solely to provide a visual context for the discussion in the text of early phases of outside-in signaling. No attempt is made to show all proteins involved or all interactions of a given protein, and important signaling cross-talk between ␣IIb␤3 and other platelet receptors is not depicted. 9 See Bearer et al, 109 Hartwig et al, 111 and Calderwood et al 124 for reviews of integrin-dependent actin dynamics and organization in platelets.
platelet aggregation. 134, 135 Moreover, currently available antiplatelet drugs, such as aspirin and clopidogrel, work in effect by dampening inside-out signaling to ␣IIb␤3. 6 Although bidirectional ␣IIb␤3 signaling is complex, novel orally active drugs may eventually be developed that target specific facets of this process. More generally, progress in integrin research can also be anticipated in several other areas of interest to hematologists, among them elucidation of the relationships between integrin polymorphisms, platelet function, and thrombotic risk; the pathogenesis of immune thrombocytopenias; the role of ␣IIb␤3 in hematopoietic stem cells 136 ; and the development of drugs that modulate integrin signaling in inflammatory diseases and cancer. Stay tuned. 51. Arias-Salgado EG, Lizano S, Sarker S, Brugge
